Patent: 8,883,146
✉ Email this page to a colleague
Summary for Patent: 8,883,146
| Title: | Protein formulations and methods of making same |
| Abstract: | The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality. |
| Inventor(s): | Fraunhofer; Wolfgang (Gurnee, IL), Bartl; Annika (Ludwigshafen, DE), Krause; Hans-Juergen (Biblis, DE), Tschoepe; Markus (Hessheim, DE), Kaleta; Katharina (Ludwigshafen, DE) |
| Assignee: | AbbVie Inc. (North Chicago, IL) |
| Application Number: | 13/774,735 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,883,146
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Centocor Ortho Biotech Products, L.p. | ORTHOCLONE OKT3 | muromanab-cd3 | Injection | 103463 | 09/14/1992 | ⤷ Try a Trial | 2027-11-30 |
| Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 12/22/1994 | ⤷ Try a Trial | 2027-11-30 |
| Aytu Bioscience, Inc. | PROSTASCINT | capromab pendetide | Injection | 103608 | 10/28/1996 | ⤷ Try a Trial | 2027-11-30 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
